Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)

Press/Media

Period	2 Jun 2024

Media coverage

Title	Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
Media name/outlet	BioSpace
Country/Territory	United States
Date	2/06/24
URL	ct.moreover.com/?a=53965944820&p=1gw&v=1&x=30s305SL5PZrszyoNer2KQ
Persons	Marshall Posner